ECSP099446A - Piperidinas sustituidas que contienen una unidad heteroarilamida o heteroarilfenilo - Google Patents

Piperidinas sustituidas que contienen una unidad heteroarilamida o heteroarilfenilo

Info

Publication number
ECSP099446A
ECSP099446A EC2009009446A ECSP099446A ECSP099446A EC SP099446 A ECSP099446 A EC SP099446A EC 2009009446 A EC2009009446 A EC 2009009446A EC SP099446 A ECSP099446 A EC SP099446A EC SP099446 A ECSP099446 A EC SP099446A
Authority
EC
Ecuador
Prior art keywords
heteroarilfenilo
heteroarilamide
piperidins
substituted
unit
Prior art date
Application number
EC2009009446A
Other languages
English (en)
Inventor
John Caldwell
Steven John Woodhead
Christopher Hamlett
Marinus Verdonk
Hannah Fiona Sore
David Winter Walker
Ian Collins
Fonseca Mchardy Tatiana Faria Da
Richard William Arthur Luke
Zbigniew Stanley Matusiak
Gregory Richard Carr
Jeffrey James Morris
Kwai Ming Cheung
Original Assignee
Astex Therapeutics Ltd
Astrazeneca Ab
Inst Cancer Res Royal Cancer Hospital
Cancer Res Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0625682A external-priority patent/GB0625682D0/en
Application filed by Astex Therapeutics Ltd, Astrazeneca Ab, Inst Cancer Res Royal Cancer Hospital, Cancer Res Tech Ltd filed Critical Astex Therapeutics Ltd
Publication of ECSP099446A publication Critical patent/ECSP099446A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención proporciona compuestos de fórmula I que tienen inhibidores de PKA y PKB quinasa de la fórmula (I): (I)o sales, solvatos, tautómeros o N-óxidos de los mismos, donde(1) GP es un grupo GP1: (GP1)(2) GP es un grupo GP2: (GP2)donde HET es un grupo heterocíclico monocíclico o bicíclico que contiene hasta 4 miembros del anillo que son heteroátomos; el anillo V es un grupo heteroarilo monocíclico o bicíclico con entre 5 y 10 miembros en el anillo; y J1, J2, R4, R7, R10, Q2a, Ga, x, w y f tienen los valores que se definen en las reivindicaciones.
EC2009009446A 2006-12-21 2009-06-19 Piperidinas sustituidas que contienen una unidad heteroarilamida o heteroarilfenilo ECSP099446A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87135506P 2006-12-21 2006-12-21
GB0625682A GB0625682D0 (en) 2006-12-21 2006-12-21 Pharmaceutical compounds
US98263607P 2007-10-25 2007-10-25
US98615007P 2007-11-07 2007-11-07

Publications (1)

Publication Number Publication Date
ECSP099446A true ECSP099446A (es) 2009-09-29

Family

ID=39301245

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009446A ECSP099446A (es) 2006-12-21 2009-06-19 Piperidinas sustituidas que contienen una unidad heteroarilamida o heteroarilfenilo

Country Status (15)

Country Link
US (1) US20100120798A1 (es)
EP (1) EP2125820A1 (es)
JP (1) JP2010513453A (es)
KR (1) KR20090104030A (es)
AR (1) AR064415A1 (es)
AU (1) AU2007335969A1 (es)
BR (1) BRPI0721124A2 (es)
CA (1) CA2672841A1 (es)
EC (1) ECSP099446A (es)
MX (1) MX2009006650A (es)
NO (1) NO20092341L (es)
PE (1) PE20081680A1 (es)
TW (1) TW200833694A (es)
UY (1) UY30823A1 (es)
WO (1) WO2008075110A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
WO2007125321A2 (en) 2006-04-25 2007-11-08 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
AU2008309383B2 (en) 2007-10-11 2012-04-19 Astrazeneca Ab Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors
US8193202B2 (en) * 2008-04-21 2012-06-05 Lexicon Pharmaceuticals, Inc. LIMK2 inhibitors, compositions comprising them, and methods of their use
JP5927201B2 (ja) 2010-12-16 2016-06-01 カルチャン リミテッド Ａｓｋ１阻害ピロロピリミジン誘導体
BR112013025410A2 (pt) 2011-04-01 2016-12-20 Astrazeneca Ab tratamento terapêutico
MD20140023A2 (ro) 2011-09-22 2014-06-30 Pfizer Inc. Derivaţi de pirolpirimidină şi purină
CA2856646C (en) 2011-11-30 2020-01-14 Astrazeneca Ab Combination treatment of cancer
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
CN104119342A (zh) * 2013-04-25 2014-10-29 苏州科捷生物医药有限公司 一种制备高纯度4-氯-5-甲基-7H-吡咯[2,3-d]嘧啶的方法
PT3980417T (pt) 2019-06-10 2023-12-28 Lupin Ltd Inibidores de prmt5

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5213229B2 (ja) * 2004-04-23 2013-06-19 エグゼリクシス， インコーポレイテッド キナーゼ調節因子および使用方法
MY179032A (en) * 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
JP5274842B2 (ja) * 2004-12-28 2013-08-28 エグゼリクシス， インコーポレイテッド 免疫疾患、炎症疾患および増殖疾患の処置のためのセリン−スレオニンキナーゼモジュレーター（ｐ７０Ｓ６Ｋ、Ａｋｔ−１およびＡｋｔ−２）としての［１Ｈ−ピペラゾ［３，４−ｄ］ピリミジン−４−イル］−ピペラジンまたは［１Ｈ−ピペラゾ［３，４−ｄ］ピリミジン−４−イル］−ピペラジン化合物
US20090082370A1 (en) * 2006-04-25 2009-03-26 Neil Thomas Thompson Pharmaceutical Combinations of PK Inhibitors and Other Active Agents
EP2029592A1 (en) * 2006-04-25 2009-03-04 Astex Therapeutics Limited Pharmaceutical compounds
JP2009534454A (ja) * 2006-04-25 2009-09-24 アステックス、セラピューティックス、リミテッド 医薬化合物

Also Published As

Publication number Publication date
TW200833694A (en) 2008-08-16
UY30823A1 (es) 2008-07-31
JP2010513453A (ja) 2010-04-30
PE20081680A1 (es) 2008-12-18
AU2007335969A1 (en) 2008-06-26
US20100120798A1 (en) 2010-05-13
WO2008075110A1 (en) 2008-06-26
EP2125820A1 (en) 2009-12-02
BRPI0721124A2 (pt) 2014-03-04
NO20092341L (no) 2009-07-21
AR064415A1 (es) 2009-04-01
MX2009006650A (es) 2009-08-20
KR20090104030A (ko) 2009-10-05
CA2672841A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
ECSP099446A (es) Piperidinas sustituidas que contienen una unidad heteroarilamida o heteroarilfenilo
ES2524966T3 (es) Derivados de tieno[3,2-c]piridina como inhibidores de quinasas para uso en el tratamiento del cáncer
ECSP099335A (es) Compuestos heterocíclicos que contienen nitrógeno y métodos de uso de los mismos
AR106237A2 (es) Inhibidores heterocíclicos de la aspartil proteasa, sus sales farmacéuticamente aceptables
UY29177A1 (es) Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
ECSP088149A (es) 3-acilaminobenzanilidas insecticidas
CL2008001017A1 (es) Compuestos derivados de indol, activadores de glucoquinasa; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de diabetes u obesidad.
PE20170774A1 (es) Compuestos de indazol como inhibidores de cinasa fgfr, preparacion y uso de los mismos
AR101816A1 (es) Derivados de 3-[(pirazol-5-il)-heteroaril]-benzamidas como agentes pesticidas
PE20110894A1 (es) Derivados de pirimidin indol para el tratamiento de cancer
NO20081893L (no) 4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft
EA201200653A1 (ru) Гетариламинохинолины
NI201000219A (es) Derivados de pirimidina como inhibidores de cinasa.
TN2010000053A1 (fr) Derives de bi cyclolactames substitues
NI201000059A (es) Inhibidores de la cinasa c-fms.
ECSP10010361A (es) Derivados de piridazinona
MY153727A (en) Pyridazinone derivatives
MX2010000658A (es) Derivados de pirimidina 934.
NO20075384L (no) Tiadiazolsubstituerte kumarinderivater og deres anvendelse som leukotrienbiosynteseinhibitorer.
PE20140970A1 (es) Derivados de 6-ciclobutil-1,5-dihidro-pirazol [3,4-d) pirimidin-4-ona y su uso como inhibidores de pde9a
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
ATE508747T1 (de) C-kit kinase-hemmer
NO20071073L (no) Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer
AR053569A1 (es) Derivados de pirazol